Present and Future of Cardiac Troponin in Clinical Practice: A Paradigm Shift to High-Sensitivity Assays

Yader Sandoval, Stephen W. Smith, Fred S. Apple

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations

Abstract

Despite its wide utilization and central role in the evaluation of patients with potential ischemic symptoms, misconceptions and confusion about cardiac troponin (cTn) prevail. The implementation of high-sensitivity (hs) cTn assays in clinical practice has multiple potential advantages provided there is an education process tied to the introduction of these assays that emphasizes the appropriate utilization of the test. Several diagnostic strategies have been explored with hs-cTn assays, including the use of undetectable values, accelerated serial hs-cTn sampling, hs-cTn measurements in combination with a clinical-risk score, and the use of a single hs-cTn measurement with a concentration threshold tailored to meet a clinical need. In this document we discuss basic concepts that should facilitate the integration of hs-cTn assays into clinical care in years to come.

Original languageEnglish (US)
Pages (from-to)354-365
Number of pages12
JournalAmerican Journal of Medicine
Volume129
Issue number4
DOIs
StatePublished - Apr 1 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc. All rights reserved.

Keywords

  • Acute myocardial infarction
  • High-sensitivity cardiac troponin
  • Troponin

Fingerprint

Dive into the research topics of 'Present and Future of Cardiac Troponin in Clinical Practice: A Paradigm Shift to High-Sensitivity Assays'. Together they form a unique fingerprint.

Cite this